- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Product Name | Swiss Prot# | Size | Price (US$) | Order |
PN1533 | Recombinant Protein-Snow goose hepatitis B virus PreC antigen (a.a.45 to 305) | Q9W8I1 | 100 µg | 1195 | |
PN1534 | Recombinant Protein-Snow goose hepatitis B virus Core antigen (a.a.1 to 262) | Q9W8R3 | 100 µg | 1195 | |
PN1535 | Recombinant Protein-Snow goose hepatitis B virus S antigen (a.a.21 to 167) | Q9WFA4 | 100 µg | 1195 | |
PN1536 | Recombinant Protein-Snow goose hepatitis B virus Large envelope protein (a.a.51 to 329) | Q9WFB3 | 100 µg | 1195 | |
RPN1533 | cDNA-Snow goose hepatitis B virus PreC antigen (a.a.45 to 305) | Q9W8I1 | 2 µg | 1300 | |
RPN1534 | cDNA-Snow goose hepatitis B virus Core antigen (a.a.1 to 262) | Q9W8R3 | 2 µg | 1305 | |
RPN1535 | cDNA-Snow goose hepatitis B virus S antigen (a.a.21 to 167) | Q9WFA4 | 2 µg | 730 | |
RPN1536 | cDNA-Snow goose hepatitis B virus large envelope protein (a.a.51 to 329) | Q9WFB3 | 2 µg | 1390 |
Snow goose hepatitis B virus cDNA and recombinant antigen
There is currently no known strain of goose hepatitis B virus. However, a virus related to hepatitis B, known as avianhepatitis E virus (HEV), has been identified in geese. HEV is a member of the avian hepadnavirus family and is found in both wild and domestic waterfowl. HEV is not known to cause disease in humans, but research suggests that it may be able to cause mild, temporary illness in people who are exposed to infected geese.
The exact answer to this question depends on what type of goose is being referred to. The general answer is that the presence of hepatitis B virus antigen in snow geese (or any other type of goose) is unknown. There have been no studies conducted to determine whether any type of goose can potentially carry hepatitis B virus antigen.
The genome of the snow goose hepatitis B virus (SGHBV) is composed of a circular DNA molecule that is approximately 3.4 kb in size. The SGHBV genome encodes four overlapping open reading frames (ORFs) with a single start codon and a single stop codon. ORF1 encodes a pre-core/core protein that is responsible for the capsid formation of the virus, while ORF2 encodes the reverse transcriptase. ORF3 and ORF4 are responsible for the production of the surface antigens, which are the main targets of the immune system. In addition, the SGHBV genome contains several regulatory elements, including an upstream promoter region and a stem-loop structure located downstream of ORF2.
The PreC antigen is a precursor to the Core antigen and is involved in the formation of new virions. The Core antigen, on the other hand, is an important structural component of the virus, forming the core of the viral particle. The Core antigen is also involved in the packaging of the viral genome, ensuring its stability and efficient replication.
The S antigen, also known as the surface antigen, is an important component of the viral envelope. It is responsible for the formation of the outer shell of the viral particle and is involved in the attachment of the virus to host cells. The S antigen is also an important target for the host immune system, and antibodies against this antigen are used in the diagnosis of hepatitis B virus infections.
The Large envelope protein, also known as L protein, is the largest protein encoded by snow goose hepatitis B virus. It is involved in the assembly and release of new virions, as well as in the formation of the viral envelope. The L protein is also known to play a role in the pathogenesis of the virus, contributing to the development of liver damage in infected individuals.
Overall, the proteins encoded by snow goose hepatitis B virus are essential for viral replication and pathogenesis. Understanding their functions is important for the development of effective treatments for hepatitis B virus infections, as well as for a better understanding of the mechanisms of viral pathogenesis in general.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple